Supernus Announces Positive Results from Two Phase III Studies For SPN-812 in Children with ADHD

World News: . []

ROCKVILLE Md Dec 06 2018 GLOBE NEWSWIRE -- Supernus Pharmaceuticals Inc NASDAQSUPN a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases today announced posit ive top...

More news and information about Supernus Pharmaceuticals, Inc.

Published By:

Globe Newswire: 12:00 GMT Thursday 6th December 2018

Published: .

Search for other references to "supernus" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us